Health Catalyst, Inc. (NASDAQ:HCAT) Stock Has Consensus Target Price of $2.15 According to Brokerages

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have received an average recommendation of “Hold” from the eight ratings firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $2.01.

Several research analysts recently commented on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Health Catalyst in a research note on Monday, October 26th. Canaccord Genuity Group downgraded Health Catalyst from a “buy” rating to a “hold” rating and reduced their target price for the company from $3.00 to $1.80 in a report on Thursday, August 20th. Wells Fargo & Company reduced their target price on Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating on the stock in a research note on Thursday, August 13th. Finally, Citigroup cut their price objective on shares of Health Catalyst from $2.50 to $2.00 and set a “neutral” rating for the company in a research report on Tuesday, August 11th.

Health Catalyst Price Performance

NASDAQ HCAT opened at $1.69 on Monday. The business’s fifty day simple moving average is $1.72 and its 200-day simple moving average is $1.72. The company has a quick ratio of 2.70, a current ratio of 2.70 and a debt-to-equity ratio of 1.51. The firm has a market cap of $127.19 million, a PE ratio of -0.46 and a beta of 1.52. Health Catalyst has a 52 week low of $0.96 and a 52 week high of $3.36.

Health Catalyst (NASDAQ:HCAT) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.01. The firm had revenue of $70.49 million during the quarter, compared to analysts’ expectations of $69.09 million. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.83%. As a group, equities analysts anticipate that Health Catalyst will post -0.18 earnings per share for the current year.

Insider Activity at Health Catalyst

In other news, CEO Simeon Kohl acquired 59,000 shares of the company’s stock in a transaction dated Monday, September 14th. The shares were bought at an average price of $1.79 per share, for a total transaction of $105,610.00. Following the completion of the purchase, the chief executive officer directly owned 2,856,385 shares of the company’s stock, valued at approximately $5,112,929.15. This trade represents a 2.11% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 19.40% of the company’s stock.

Institutional Trading of Health Catalyst

Institutional investors and hedge funds have recently made changes to their positions in the stock. Squarepoint Ops LLC boosted its holdings in shares of Health Catalyst by 1,214.8% in the second quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock valued at $796,000 after acquiring an additional 369,772 shares in the last quarter. AXQ Capital LP acquired a new stake in Health Catalyst during the second quarter valued at approximately $38,000. Headlands Technologies LLC bought a new stake in Health Catalyst during the second quarter worth approximately $131,000. Hsbc Holdings PLC boosted its holdings in Health Catalyst by 313.3% during the second quarter. Hsbc Holdings PLC now owns 408,634 shares of the company’s stock worth $809,000 after buying an additional 309,766 shares in the last quarter. Finally, Palogic Value Management L.P. acquired a new position in Health Catalyst in the second quarter worth approximately $9,796,000. 85.00% of the stock is currently owned by institutional investors and hedge funds.

Health Catalyst Company Profile

Health Catalyst, Inc is a healthcare technology company that provides data and analytics solutions to help healthcare organizations improve clinical outcomes, operational efficiency and financial performance. Its customers include hospitals, health systems, medical groups and other healthcare organizations seeking to integrate and analyze data from across their operations.

The company’s offerings are built around its Health Catalyst Data Operating System, a cloud-based platform designed to combine information from electronic health records, financial systems and other sources.